ETGLX (ETGLX) Stock Price & Analysis
ETGLX (ETGLX) rose 0.63% to USD 61.17 as of June 10, 2026 at 17:43 UTC, according to Nexqual real-time market data.
ETGLX last closed at USD 60.79; the session ranged USD 61.17–61.17 on volume of 0 shares. Market capitalization is —, with a 52-week range of USD 48.82–62.48 (NAS). Source: Nexqual, June 10, 2026 at 17:43 UTC.
Key Statistics (as of June 10, 2026 at 17:43 UTC)
| Price | USD 61.17 |
|---|---|
| Change | ▲ 0.63% (up) |
| Previous Close | USD 60.79 |
| Open | USD 61.17 |
| Day Range | USD 61.17 – 61.17 |
| 52-Week Range | USD 48.82 – 62.48 |
| Volume | 0 shares |
| Market Cap | — |
| Exchange | NAS |
Technical Analysis (ETGLX)
Nexqual's technical model rates ETGLX "STRONG BUY" based on 5 bullish and 0 bearish signals across 124 daily candles, as of June 10, 2026 at 17:43 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 60.06 (neutral) |
| vs SMA50 | Above (USD 57.07) |
| MACD | 1.22 (positive) |
Financial Health Score (ETGLX)
Nexqual rates ETGLX's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 17:43 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Mixed — No data |
| Balance Sheet | Mixed — No data |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — No data |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ETNHX | Eventide Healthcare & Life Scie | USD 47.61 | ▲ 2.15% |
| ETILX | Eventide Gilead Fund Institutio | USD 63.84 | ▲ 0.61% |
| GTLLX | Glenmede Large Cap Growth Ptf | USD 32.22 | ▼ 0.43% |
| BUFOX | Buffalo Early Stage Growth Fund | USD 18.04 | ▲ 0.39% |
| PARWX | Parnassus Endeavor Fund - Inves | USD 62.37 | ▲ 0.76% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 17:43 UTC. This page is informational and not investment advice.